brimonidine tartrate has been researched along with alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arencibia-Albite, F; Figueroa, J; Jiménez-Rivera, CA; Schwarz, D; Vázquez-Torres, R; Velásquez-Martinez, MC; Vélez-Hernandez, ME | 1 |
1 other study(ies) available for brimonidine tartrate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
| Article | Year |
|---|---|
Presynaptic inhibition of glutamate transmission by α2 receptors in the VTA.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Brimonidine Tartrate; Clonidine; Dopaminergic Neurons; Dose-Response Relationship, Drug; Enzyme Inhibitors; Excitatory Amino Acids; Excitatory Postsynaptic Potentials; Glutamic Acid; In Vitro Techniques; Male; Mice; Neural Inhibition; Patch-Clamp Techniques; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Sodium Channel Blockers; Tetrodotoxin; Ventral Tegmental Area | 2012 |